{"protocolSection": {"identificationModule": {"nctId": "NCT01471340", "orgStudyIdInfo": {"id": "P06241"}, "secondaryIdInfos": [{"id": "2011-002142-13", "type": "EUDRACT_NUMBER"}, {"id": "MK-0887A-202", "type": "OTHER", "domain": "Merck Protocol Number"}], "organization": {"fullName": "Organon and Co", "class": "INDUSTRY"}, "briefTitle": "A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)", "officialTitle": "A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate/Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and Adults With Persistent Asthma (Protocol No. P06241 Also Known as P202)", "acronym": "SPIRO"}, "statusModule": {"statusVerifiedDate": "2024-04", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2012-01-09", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2016-11-30", "type": "ACTUAL"}, "completionDateStruct": {"date": "2016-11-30", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-11-10", "studyFirstSubmitQcDate": "2011-11-14", "studyFirstPostDateStruct": {"date": "2011-11-16", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2017-11-07", "resultsFirstSubmitQcDate": "2018-01-04", "resultsFirstPostDateStruct": {"date": "2018-01-05", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2024-05-09", "lastUpdatePostDateStruct": {"date": "2024-05-23", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Organon and Co", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true, "isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "The purpose of this study is to test the safety of DULERA. DULERA is a pressurized metered-dose inhaler (MDI) that contains two drugs combined, namely mometasone and formoterol in a single inhaler. Mometasone is an inhaled corticosteroid (ICS), which reduces the inflammation in the airways. Formoterol is a long-acting beta 2 agonist (LABA), which helps to relax the muscles of the airways in the lungs, making it easier to breathe. In combination, mometasone and formoterol are used for the treatment of asthma. This study will evaluate whether participants taking a LABA in combination with an ICS in a single inhaler have a different risk of having serious asthma events (hospitalization, intubation and death) compared to participants taking an ICS alone. The primary safety hypothesis is that the time-to-first serious asthma outcome (SAO) with mometasone furoate/formoterol (MF/F) MDI twice daily (BID) is non-inferior to that with mometasone furoate (MF) MDI BID in adolescents and adults with persistent asthma. If non-inferiority is achieved, the key secondary safety hypothesis of superiority of MF/F over MF will be assessed.", "detailedDescription": "Amendments 2 and 3 are specific to Brazil; all other countries will enroll patients under Amendment 1."}, "conditionsModule": {"conditions": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 11744, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Mometasone Furoate/Formoterol MDI BID", "type": "EXPERIMENTAL", "description": "MF/F MDI BID (pooled MF/F MDI 200/10 mcg BID and MF/F MDI 400/10 mcg BID treatments)", "interventionNames": ["Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg", "Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg", "Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI", "Drug: Prednisone/prednisolone"]}, {"label": "Mometasone Furoate MDI BID", "type": "ACTIVE_COMPARATOR", "description": "MF MDI BID (pooled from MF MDI 200 mcg BID and MF MDI 400 mcg BID treatments)", "interventionNames": ["Drug: Mometasone Furoate MDI 100 mcg", "Drug: Mometasone Furoate MDI 200 mcg", "Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI", "Drug: Prednisone/prednisolone"]}], "interventions": [{"type": "DRUG", "name": "Mometasone Furoate/Formoterol MDI 100/5 mcg", "description": "two inhalations BID", "armGroupLabels": ["Mometasone Furoate/Formoterol MDI BID"], "otherNames": ["MK-0887A; Dulera/Zenhale"]}, {"type": "DRUG", "name": "Mometasone Furoate/Formoterol MDI 200/5 mcg", "description": "two inhalations BID", "armGroupLabels": ["Mometasone Furoate/Formoterol MDI BID"], "otherNames": ["MK-0887A; Dulera/Zenhale"]}, {"type": "DRUG", "name": "Mometasone Furoate MDI 100 mcg", "description": "two inhalations BID", "armGroupLabels": ["Mometasone Furoate MDI BID"], "otherNames": ["Asmanex"]}, {"type": "DRUG", "name": "Mometasone Furoate MDI 200 mcg", "description": "two inhalations BID", "armGroupLabels": ["Mometasone Furoate MDI BID"], "otherNames": ["Asmanex"]}, {"type": "DRUG", "name": "Albuterol 90 mcg /salbutamol 100 mcg HFA MDI", "description": "use as needed for asthma symptoms", "armGroupLabels": ["Mometasone Furoate MDI BID", "Mometasone Furoate/Formoterol MDI BID"]}, {"type": "DRUG", "name": "Prednisone/prednisolone", "description": "Oral prednisone/prednisolone used only as an emergency rescue medication at the discretion of the investigator", "armGroupLabels": ["Mometasone Furoate MDI BID", "Mometasone Furoate/Formoterol MDI BID"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Time-to-First Serious Asthma Outcomes (SAO): Number of First SAO in the MF/F vs MF Arms", "description": "The primary safety outcome was the time-to-first SAO (a composite endpoint of adjudicated asthma-related hospitalizations, adjudicated asthma-related intubations, and adjudicated asthma-related deaths). To accomplish this, the number of participants experiencing a first SAO was collected for 26 weeks following initiation of study treatment (or 7 days after the last treatment dose, whichever occurred later). Data generated by this methodology were used to compute a hazard ratio (HR) and 95% confidence interval (CI), modeling the likelihood of a first SAO occurring at any given time in the MF/F arm relative to the MF arm. Although data were sufficient to generate a HR and 95% CI, time-to-first SAO in the overall population could not be accurately reported due to insufficient SAO occurrence. Therefore, the number of first SAO in either arm is reported as a descriptive measure. For each participant, first SAO denotes first event per participant.", "timeFrame": "26 weeks, or 7 days after the last treatment dose, whichever occurred later"}], "secondaryOutcomes": [{"measure": "Time-to-First Severe Asthma Exacerbation (SAEX): Number of First SAEX in the MF/F vs MF Arms", "description": "The key secondary efficacy outcome was time-to-first protocol-defined asthma exacerbation (SAEX). The SAEX were deteriorations of asthma requiring: use of systemic corticosteroids (tablets, suspension, or injection) for \\>= 3 consecutive days, in-patient hospitalization \\>= 24 hours, or an emergency department (ED) visit \\< 24 hours that required systemic corticosteroids in the MF/F MDI BID arm versus the MF MDI BID arm. The number of first SAEX occurred from initiation of study treatment to 7 days after the last treatment (modified intention-to-treat). This outcome was measured as the HR and 95% CI for the number of first SAEX in the MF/F MDI BID arm versus the number of first SAEX in the MF MDI BID arm. Given insufficient data for SAEX events, it was not informative to report the time-to-first SAEX in the overall population. Therefore, the number of first SAEXs in either arm is reported as a descriptive measure. For each participant, first SAEX denotes first event per participant.", "timeFrame": "26 weeks, plus 7 days after the last treatment"}], "otherOutcomes": [{"measure": "Number of SAO Components in MF/F Participants vs MF Participants", "description": "To further examine the primary safety outcome, each adjudicated component of the SAO composite endpoint (asthma-related hospitalization, asthma-related intubation and asthma-related death), was tabulated for descriptive purposes only to show the relative contribution of each component to the SAO composite. Hospitalizations were defined as an in-patient stay of \\>= 24 hour in a hospital, emergency department or equivalent healthcare facility. Intubation was defined as endotracheal intubation only.", "timeFrame": "26 weeks, or 7 days after the last treatment dose, whichever occurred later"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Persistent asthma for at least 1-year\n* Must use a daily asthma controller medication for at least 4 weeks prior to randomization, including an inhaled corticosteroid (ICS) with or without a long-acting beta agonist (LABA) or other adjunctive asthma therapy OR be using a leukotriene receptor antagonist (LTRA), xanthine or short acting beta agonist (SABA) as a monotherapy.\n* Must be able to discontinue current asthma medication\n* Must have a history of at least one asthma exacerbation in previous 4 to 52 weeks\n\nExclusion Criteria:\n\n* Unstable asthma\n* Taking high dose ICS with or without other adjunctive therapy who have an Asthma Control Questionnaire 6 (ACQ6) total score \u2265 1.5\n* Taking LTRA, xanthine or SABA monotherapy with an ACQ-6 total score \\< 1.5 (controlled)\n* Chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), or other significant, non-asthmatic, lung disease\n* Clinically significant abnormality, illness or disorder of any body or organ system\n* Significant underlying cardiovascular condition which may contraindicate use of a beta-agonist.\n* History of smoking greater than 10-pack years\n* Had an asthma exacerbation within 4 weeks of the Baseline Visit\n* Had more than 4 asthma exacerbations or 2 hospitalizations within 52 weeks of the randomization visit\n* Known or suspected hypersensitivity or intolerance to corticosteroids, beta-2 agonists, or any of the (inactive ingredients) excipients present in the medications used in this study\n* Require the use of chronic systemic steroids, omalizumab, or other monoclonal or polyclonal antibodies\n* Requires the use of beta-blockers\n* History of life-threatening asthma, including an asthma episode that required intubation and/or was associated with hypercapnia requiring noninvasive ventilatory support\n* Lactating, pregnant, or plans to become pregnant during the course of the trial", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "12 Years", "stdAges": ["CHILD", "ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Medical Director", "affiliation": "Merck Sharp & Dohme LLC", "role": "STUDY_DIRECTOR"}]}, "referencesModule": {"references": [{"pmid": "30537475", "type": "RESULT", "citation": "Weinstein CLJ, Ryan N, Shekar T, Gates D, Lane SJ, Agache I, Nathan RA; SPIRO Investigators. Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate. J Allergy Clin Immunol. 2019 Apr;143(4):1395-1402. doi: 10.1016/j.jaci.2018.10.065. Epub 2018 Dec 8."}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"recruitmentDetails": "11,744 participants were enrolled in the study and 11,729 participants were randomized and received at least one dose of blinded study treatment (defined as the number started). Treatments were Mometasone Furoate/Formoterol (MF/F) metered dose inhaler (MDI) twice daily (BID) and Mometasone Furoate (MF) MDI BID.", "groups": [{"id": "FG000", "title": "Mometasone Furoate/Formoterol (MF/F) MDI BID", "description": "MF/F MDI administered as two puffs of 100/5 mcg or 200/5 mcg, twice daily (pooled MF/F treatments), with oral inhalation of a pressurized inhalation aerosol"}, {"id": "FG001", "title": "Mometasone Furoate (MF) MDI BID", "description": "MF MDI administered as two puffs of 100 mcg or 200 mcg, twice daily (pooled MF treatments), with oral inhalation of a pressurized inhalation aerosol"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "comment": "This value corresponds to randomized participants who received at least of dose of study medication", "numSubjects": "5868"}, {"groupId": "FG001", "comment": "This value corresponds to randomized participants who received at least of dose of study medication", "numSubjects": "5861"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "5862"}, {"groupId": "FG001", "numSubjects": "5855"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "6"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "4"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Investigational site closure", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Invalid informed consent", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "These are all participants who were randomized and treated with at least one dose of study medication", "groups": [{"id": "BG000", "title": "Mometasone Furoate/Formoterol (MF/F) MDI BID", "description": "MF/F MDI administered as two puffs of 100/5 mcg or 200/5 mcg, twice daily, with oral inhalation of a pressurized inhalation aerosol"}, {"id": "BG001", "title": "Mometasone Furoate (MF) MDI BID", "description": "MF MDI administered as two puffs of 100 mcg or 200 mcg, twice daily, with oral inhalation of a pressurized inhalation aerosol"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "5868"}, {"groupId": "BG001", "value": "5861"}, {"groupId": "BG002", "value": "11729"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "45.3", "spread": "17.19"}, {"groupId": "BG001", "value": "44.8", "spread": "17.55"}, {"groupId": "BG002", "value": "45.1", "spread": "17.37"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "3841"}, {"groupId": "BG001", "value": "3875"}, {"groupId": "BG002", "value": "7716"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "2027"}, {"groupId": "BG001", "value": "1986"}, {"groupId": "BG002", "value": "4013"}]}]}]}, {"title": "Treatment Covariates (MF/F or MF) and ICS Dose Level (100 or 200 mcg, per actuation)", "description": "The primary safety hypothesis will be evaluated using Cox proportional-hazard model including covariates of treatment (MF/F MDI BID vs MF MDI BID) and ICS dose level (100 mcg vs 200 mcg, per actuation).", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "MF/F 200/10 mcg", "categories": [{"measurements": [{"groupId": "BG000", "value": "3604"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "3604"}]}]}, {"title": "MF/F 400/10 mcg", "categories": [{"measurements": [{"groupId": "BG000", "value": "2264"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "2264"}]}]}, {"title": "MF 200 mcg", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "3601"}, {"groupId": "BG002", "value": "3601"}]}]}, {"title": "MF 400 mcg", "categories": [{"measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "2260"}, {"groupId": "BG002", "value": "2260"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Time-to-First Serious Asthma Outcomes (SAO): Number of First SAO in the MF/F vs MF Arms", "description": "The primary safety outcome was the time-to-first SAO (a composite endpoint of adjudicated asthma-related hospitalizations, adjudicated asthma-related intubations, and adjudicated asthma-related deaths). To accomplish this, the number of participants experiencing a first SAO was collected for 26 weeks following initiation of study treatment (or 7 days after the last treatment dose, whichever occurred later). Data generated by this methodology were used to compute a hazard ratio (HR) and 95% confidence interval (CI), modeling the likelihood of a first SAO occurring at any given time in the MF/F arm relative to the MF arm. Although data were sufficient to generate a HR and 95% CI, time-to-first SAO in the overall population could not be accurately reported due to insufficient SAO occurrence. Therefore, the number of first SAO in either arm is reported as a descriptive measure. For each participant, first SAO denotes first event per participant.", "populationDescription": "The analyzed population for assessment of the number of first SAO was all participants who received at least one dose of randomized treatment assignment (intention-to-treat principle).", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Serious asthma outcomes", "timeFrame": "26 weeks, or 7 days after the last treatment dose, whichever occurred later", "groups": [{"id": "OG000", "title": "MF/F MDI BID", "description": "MF/F MDI administered as two puffs of 100/5 mcg or 200/5 mcg, twice daily (pooled MF/F treatments), with oral inhalation of a pressurized inhalation aerosol"}, {"id": "OG001", "title": "MF MDI BID", "description": "MF MDI administered as two puffs of 100 mcg or 200 mcg, twice daily (pooled MF treatments), with oral inhalation of a pressurized inhalation aerosol"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5868"}, {"groupId": "OG001", "value": "5861"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "32"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Pertains only to the First SAO; pooled MF/F treatments and pooled MF treatments", "nonInferiorityType": "NON_INFERIORITY_OR_EQUIVALENCE_LEGACY", "nonInferiorityComment": "The projected sample size provided 90% power at a 2.5% alpha level (one-sided) to determine non-inferiority of MF/F and MF. For analysis of the first SAO in participants, MF/F MDI BID was considered non-inferior to MF MDI BID if the upper bound for the 95% confidence interval (CI) of the hazard ratio (HR) of MF/F MDI BID versus MF MDI BID was lower than 2.0 (noninferiority margin).", "pValue": "0.411", "statisticalMethod": "Cox proportional-hazard model", "paramType": "Hazard Ratio (HR)", "paramValue": "1.22", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.76", "ciUpperLimit": "1.94", "estimateComment": "The HR and 95% CI were based on the Cox proportional-hazard model with covariates of treatment (MF/F or MF) and ICS dose level (200 or 400 mcg)."}]}, {"type": "SECONDARY", "title": "Time-to-First Severe Asthma Exacerbation (SAEX): Number of First SAEX in the MF/F vs MF Arms", "description": "The key secondary efficacy outcome was time-to-first protocol-defined asthma exacerbation (SAEX). The SAEX were deteriorations of asthma requiring: use of systemic corticosteroids (tablets, suspension, or injection) for \\>= 3 consecutive days, in-patient hospitalization \\>= 24 hours, or an emergency department (ED) visit \\< 24 hours that required systemic corticosteroids in the MF/F MDI BID arm versus the MF MDI BID arm. The number of first SAEX occurred from initiation of study treatment to 7 days after the last treatment (modified intention-to-treat). This outcome was measured as the HR and 95% CI for the number of first SAEX in the MF/F MDI BID arm versus the number of first SAEX in the MF MDI BID arm. Given insufficient data for SAEX events, it was not informative to report the time-to-first SAEX in the overall population. Therefore, the number of first SAEXs in either arm is reported as a descriptive measure. For each participant, first SAEX denotes first event per participant.", "populationDescription": "The analyzed population for assessment of the number of first asthma exacerbations was all treated participants who received at least one dose of randomized treatment assignment (intention-to-treat principle).", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Asthma exacerbations", "timeFrame": "26 weeks, plus 7 days after the last treatment", "groups": [{"id": "OG000", "title": "MF/F MDI BID", "description": "MF/F MDI administered as two puffs of 100/5 mcg or 200/5 mcg, twice daily (pooled MF/F treatments), with oral inhalation of a pressurized inhalation aerosol"}, {"id": "OG001", "title": "MF MDI BID", "description": "MF MDI administered as two puffs of 100 mcg or 200 mcg, twice daily (pooled MF treatments), with oral inhalation of a pressurized inhalation aerosol"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5868"}, {"groupId": "OG001", "value": "5861"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "708"}, {"groupId": "OG001", "value": "779"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "groupDescription": "Pertains only to the First SAEX; pooled MF/F treatments and pooled MF treatments", "nonInferiorityType": "SUPERIORITY_OR_OTHER_LEGACY", "pValue": "0.021", "statisticalMethod": "Cox proportional-hazard model", "statisticalComment": "Superiority of MF/F MDI BID vs MF MDI BID was determined if the HR was less than 1 and achieved statistical significance (one-sided p-value \\< 0.025).", "paramType": "Hazard Ratio (HR)", "paramValue": "0.89", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.80", "ciUpperLimit": "0.98", "estimateComment": "The HR and 95% CI were based on the Cox proportional-hazard model with covariates of treatment (MF/F or MF) and ICS dose level (200 or 400 mcg)."}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of SAO Components in MF/F Participants vs MF Participants", "description": "To further examine the primary safety outcome, each adjudicated component of the SAO composite endpoint (asthma-related hospitalization, asthma-related intubation and asthma-related death), was tabulated for descriptive purposes only to show the relative contribution of each component to the SAO composite. Hospitalizations were defined as an in-patient stay of \\>= 24 hour in a hospital, emergency department or equivalent healthcare facility. Intubation was defined as endotracheal intubation only.", "populationDescription": "The analyzed population for tabulation of the number of SAO components was all participants who received at least one dose of randomized treatment assignment (intention-to-treat principle).", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "SAO components", "timeFrame": "26 weeks, or 7 days after the last treatment dose, whichever occurred later", "groups": [{"id": "OG000", "title": "MF/F MDI BID", "description": "MF/F MDI administered as two puffs of 100/5 mcg or 200/5 mcg, twice daily (pooled MF/F treatments), with oral inhalation of a pressurized inhalation aerosol"}, {"id": "OG001", "title": "MF MDI BID", "description": "MF MDI administered as two puffs of 100 mcg or 200 mcg, twice daily (pooled MF treatments), with oral inhalation of a pressurized inhalation aerosol"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "5868"}, {"groupId": "OG001", "value": "5861"}]}], "classes": [{"title": "First SAO", "categories": [{"measurements": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "32"}]}]}, {"title": "Asthma-related hospitalizations", "categories": [{"measurements": [{"groupId": "OG000", "value": "39"}, {"groupId": "OG001", "value": "32"}]}]}, {"title": "Asthma-related intubations", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Asthma-related deaths", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "26 weeks, or 7 days after the last treatment dose, whichever occurred later", "description": "All serious adverse events are reported. Only those non-serious (Other) adverse events leading to treatment discontinuation were collected during the study, and are reported here.", "eventGroups": [{"id": "EG000", "title": "MF/F MDI BID", "deathsNumAffected": 5, "deathsNumAtRisk": 5868, "seriousNumAffected": 136, "seriousNumAtRisk": 5868, "otherNumAffected": 67, "otherNumAtRisk": 5868}, {"id": "EG001", "title": "MF MDI BID", "deathsNumAffected": 4, "deathsNumAtRisk": 5861, "seriousNumAffected": 137, "seriousNumAtRisk": 5861, "otherNumAffected": 75, "otherNumAtRisk": 5861}], "seriousEvents": [{"term": "Leukocytosis", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Acute myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Atrial tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Atrioventricular block complete", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Atrioventricular block second degree", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Cardiomegaly", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Coronary artery thrombosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Diastolic dysfunction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Mitral valve stenosis", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Hypertrophic cardiomyopathy", "organSystem": "Congenital, familial and genetic disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Vertigo positional", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Autoimmune thyroiditis", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Basedow's disease", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Retinal detachment", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Epiploic appendagitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Functional gastrointestinal disorder", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Gastric dysplasia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Gastrointestinal necrosis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Gastrooesophageal reflux disease", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Gastrooesophageal sphincter insufficiency", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Ileus", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Inguinal hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Pancreatitis chronic", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Subileus", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Umbilical hernia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Systemic inflammatory response syndrome", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Biliary colic", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Cholangitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Cholecystitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Cholecystitis acute", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Cholecystitis chronic", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Cholelithiasis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Food allergy", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Abscess intestinal", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Anicteric leptospirosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Appendicitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 5861}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Clostridium difficile colitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Diverticulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Eczema infected", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Helicobacter gastritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Infectious mononucleosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Lower respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Meningitis cryptococcal", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Meningitis viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Peritonitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Peritonsillar abscess", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Pilonidal cyst", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 10, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 5861}]}, {"term": "Pneumonia bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Pneumonia pseudomonal", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Post procedural infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Pyelonephritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Viral infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Accidental overdose", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Ankle fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 5861}]}, {"term": "Burns third degree", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Facial bones fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Fall", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Head injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Intentional product misuse", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Joint dislocation", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Limb injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Lower limb fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Meniscus injury", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Radius fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Subdural haematoma", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Tibia fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 5861}]}, {"term": "Ulna fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Chest X-ray abnormal", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Diabetes mellitus inadequate control", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Diabetic ketoacidosis", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Hyperkalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Hyperosmolar state", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Hypokalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Obesity", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Arthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Chondropathy", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Intervertebral disc protrusion", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Joint range of motion decreased", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Osteoarthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Osteolysis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Rhabdomyolysis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Rotator cuff syndrome", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Spondylolisthesis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Benign neoplasm of spinal cord", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Breast cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Carcinoid tumour of the duodenum", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Hepatic cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Intraductal proliferative breast lesion", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Lung adenocarcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Medullary thyroid cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Ovarian adenoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Renal cancer", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Uterine leiomyoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Cervicobrachial syndrome", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Encephalitis autoimmune", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Facial paresis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Hemiparesis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "IIIrd nerve paralysis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Ischaemic stroke", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Lacunar infarction", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Multiple sclerosis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Sciatica", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Spondylitic myelopathy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Trigeminal neuralgia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Abortion incomplete", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Abortion missed", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Abortion spontaneous", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Ectopic pregnancy", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Foetal death", "organSystem": "Pregnancy, puerperium and perinatal conditions", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Acute psychosis", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Alcohol abuse", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Alcoholism", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Anxiety", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Anxiety disorder", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Completed suicide", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Depression", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Major depression", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Schizophreniform disorder", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Acute kidney injury", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Calculus urinary", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Nephrolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Renal tubular necrosis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Fibrocystic breast disease", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Ovarian cyst", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Postmenopausal haemorrhage", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Varicocele", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 34, "numAffected": 32, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 34, "numAffected": 31, "numAtRisk": 5861}]}, {"term": "Asthmatic crisis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Atelectasis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Bronchiectasis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Bronchospasm", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Haemoptysis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Interstitial lung disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Nasal septum deviation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Organising pneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Pneumonia aspiration", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Pneumonitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Pulmonary embolism", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 5861}]}, {"term": "Pulmonary oedema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Respiratory disorder", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Angioedema", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Skin hypertrophy", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Urticaria", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Deep vein thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Varicose vein", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Acute coronary syndrome", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}], "otherEvents": [{"term": "Angina pectoris", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Hypertension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Heart rate increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Chest discomfort", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 5861}]}, {"term": "Palpitations", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Supraventricular tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Tachycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Non-cardiac chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Hot flush", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Lichen planus", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Dermatitis acneiform", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Feeling jittery", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Tongue discomfort", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Hypersensitivity", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Laryngeal hypertrophy", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Weight increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Stomatitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 5861}]}, {"term": "Retching", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Bronchospasm paradoxical", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Dry mouth", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Dysphonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 5861}]}, {"term": "Throat irritation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Hypopnea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Conjunctivitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 5861}]}, {"term": "Drug hypersensitivity", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Insomnia", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Dyspnea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 4, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 5861}]}, {"term": "Sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Tremor", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Oral candidiasis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Pharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Laryngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Candida infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Asthenia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Dysgeusia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Wheezing", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 5861}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 5861}]}, {"term": "Oral discomfort", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Anxiety", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Pruritus", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Rhinitis allergic", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Glossodynia", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Rash", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Rash maculo-papular", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Oral mucosal erythema", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 5861}]}, {"term": "Muscle spasms", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Allergic edema", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Vocal cord disorder", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 5861}]}, {"term": "Vertigo", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Alopecia", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Urticaria", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Respiratory tract congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Mouth ulceration", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Mucosal inflammation", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Lower respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Oral fungal infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Joint swelling", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Oropharyngeal candidiasis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Bronchospasm", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Aphonia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Oropharyngeal pain", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 5861}]}, {"term": "Epilepsy", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Laryngeal edema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}, {"term": "Adverse drug reaction", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 19.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 5868}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 5861}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The investigator agrees not to publish or publicly present any interim results of the trial without the prior written consent of the sponsor, and to provide the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication which report any trial results. The sponsor has the right to review and comment on publications, abstracts, slides, and manuscripts, and to review and comment on data analysis and presentation."}, "pointOfContact": {"title": "Senior Vice President, Global Clinical Development", "organization": "Merck Sharp & Dohme Corp.", "email": "ClinicalTrialsDisclosure@merck.com", "phone": "1-800-672-6372"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Argentina", "Australia", "Brazil", "Bulgaria", "Canada", "Chile", "China", "Colombia", "Croatia", "Czech Republic", "Estonia", "France", "Germany", "Guatemala", "Hungary", "Ireland", "Israel", "Italy", "Korea, Republic of", "Latvia", "Malaysia", "Mexico", "Peru", "Poland", "Puerto Rico", "Romania", "Russian Federation", "Serbia", "Slovakia", "South Africa", "Spain", "Taiwan", "Ukraine", "United Kingdom", "United States"]}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068656", "term": "Mometasone Furoate"}, {"id": "D000011241", "term": "Prednisone"}, {"id": "D000011239", "term": "Prednisolone"}, {"id": "D000000420", "term": "Albuterol"}, {"id": "D000068759", "term": "Formoterol Fumarate"}, {"id": "D000068758", "term": "Mometasone Furoate, Formoterol Fumarate Drug Combination"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018931", "term": "Antineoplastic Agents, Hormonal"}, {"id": "D000000970", "term": "Antineoplastic Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000058666", "term": "Adrenergic beta-2 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000015149", "term": "Tocolytic Agents"}, {"id": "D000012102", "term": "Reproductive Control Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}], "browseLeaves": [{"id": "M11749", "name": "Methylprednisolone", "relevance": "LOW"}, {"id": "M1833", "name": "Methylprednisolone Acetate", "relevance": "LOW"}, {"id": "M11750", "name": "Methylprednisolone Hemisuccinate", "relevance": "LOW"}, {"id": "M14120", "name": "Prednisolone", "asFound": "Direct", "relevance": "HIGH"}, {"id": "M229449", "name": "Prednisolone acetate", "relevance": "LOW"}, {"id": "M211887", "name": "Prednisolone hemisuccinate", "relevance": "LOW"}, {"id": "M248881", "name": "Prednisolone phosphate", "relevance": "LOW"}, {"id": "M3767", "name": "Albuterol", "asFound": "Diameter", "relevance": "HIGH"}, {"id": "M14121", "name": "Prednisone", "asFound": "Min", "relevance": "HIGH"}, {"id": "M290", "name": "Mometasone Furoate", "asFound": "Tea", "relevance": "HIGH"}, {"id": "M304", "name": "Formoterol Fumarate", "asFound": "Nicotine", "relevance": "HIGH"}, {"id": "M303", "name": "Mometasone Furoate, Formoterol Fumarate Drug Combination", "asFound": "Cartilaginous", "relevance": "HIGH"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M20966", "name": "Antineoplastic Agents, Hormonal", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}, {"id": "M17869", "name": "Tocolytic Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "AnEm", "name": "Antiemetics"}, {"abbrev": "NeuroAg", "name": "Neuroprotective Agents"}, {"abbrev": "Gast", "name": "Gastrointestinal Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "ANeo", "name": "Antineoplastic Agents"}, {"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}]}}, "hasResults": true}